𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men

✍ Scribed by Fabiana B. Kohlrausch; Rita De Cássia Estrela; Paulo F. Barroso; Guilherme Suarez-Kurtz


Book ID
108642420
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
381 KB
Volume
69
Category
Article
ISSN
0306-5251

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Management of drug-to-drug interactions
✍ Martin Vogel; Esther Voigt; Hans-Christoph Michaelis; Thomas Sudhop; Martin Wolf 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

Highly active antiretroviral therapy (HAART) has improved the life expectancy of HIV-infected patients, allowing orthotopic liver transplantation as a reasonable treatment option for selected patients with terminal liver disease. Both non-nucleoside reverse transcriptase inhibitors and protease inhi

Impact of the Alcohol-Dehydrogenase (ADH
✍ Keitaro Matsuo; Akio Hiraki; Kaoru Hirose; Hidemi Ito; Takeshi Suzuki; Kenji Wak 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

A linkage disequilibrium (LD) between the alcohol-dehydrogenase 1B (ADH1B) and alcohol-dehydrogenase 1C (ADH1C) polymorphisms adds complexity to differentiating the significance of these two genetic polymorphisms on drinking behavior and alcoholism. We have recently shown the importance of the ADH1B

Predictive value of drug levels, HIV gen
✍ Luisa Valer; Carmen de Mendoza; Vincent Soriano 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Plasma levels of HIV protease inhibitors (PI) are often close to IC50 values of wild-type viruses when administered without ritonavir boosting. The impact of drug levels, resistance mutations, and the genotypic inhibitory quotient (GIQ) were examined on the response to saquinavir/ritonavir (SQV/r)-b